Mesable 400 Tablet contains Mesalazine 400mg, a gastrointestinal anti-inflammatory agent used in the management of ulcerative colitis, inflammatory bowel disease (IBD), and related GI inflammation.
It works locally in the colon to reduce inflammation, relieve abdominal pain, and control diarrhea and rectal bleeding, supporting mucosal healing and long-term disease management.
Mesable 400 Tablet belongs to the gastroenterology and anti-inflammatory therapy segment, prescribed by gastroenterologists and general physicians for long-term management of IBD and ulcerative colitis.
For PCD pharma franchise partners, distributors, and exporters, Mesable 400 Tablet offers a high-demand opportunity due to increasing cases of gastrointestinal disorders. It is available for bulk supply, monopoly-based PCD franchise, third-party manufacturing, institutional distribution, and export, ensuring profitable business growth.